Posts

Sage Anticipates Job Cuts and Project Scaling Down Foll...

In response to the recent decision by the FDA to decline the Biogen-partnered dr...

Bristol Myers Squibb Launches Sotyktu Initiative to Pro...

Bristol Myers Squibb is actively working to shed light on the intricate realitie...

Novo’s Wegovy Successful in Reducing Risk of Cardiovasc...

In a large Phase 3 trial that enrolled over 17,600 participants aged 45 and olde...

Amid backlash, Novo Nordisk reports positive cardiovasc...

Wegovy has been approved in the US and Europe for weight loss management in pati...

Jacobio Pharma receives breakthrough therapy designatio...

Jacobio Pharma received breakthrough therapy designation (BTD) for glecirasib to...

Danam signs merger agreement with Artemis

Danam Health has signed a merger deal with publicly traded special purpose acqui...

Artificial intelligence is set to power the future of h...

An increasing amount of information make artificial intelligence (AI) stand out ...

Ginkgo Bioworks and Merck partner to bolster biologic m...

Ginkgo Bioworks has entered into a new partnership with Merck (MSD) to bolster b...

FDA accepts review of Viatris and Mapi’s NDA filing for...

The US Food and Drug Administration (FDA) has accepted for review Viatris and Ma...

Navigating market access in Sweden

Pricing and reimbursement of pharmaceuticals is changing in Sweden, with prices ...

Astellas invests $50m in Poseida’s CAR-T cell therapy

As part of the agreement, Astellas will have exclusive negotiation and first ref...

J&J signs Stelara biosimilar settlement deal with Formy...

The deal sets the biosimilar’s potential US launch date to no later than April 2...

Arcus and Gilead terminate development for etrumadenant...

However, the adenosine receptor antagonist is still being developed for the trea...

A new study put period products through the wringer. Di...

There are many period products on the market from pads, tampons and cups to disc...

STAT+: Nektar Therapeutics sues Lilly for ‘misconduct’ ...

Nektar Therapeutics filed a lawsuit accusing Eli Lilly of undermining a drug dev...

STAT+: Sage considers ways to reduce costs following FD...

Sage Therapeutics said Monday that it may need to reduce costs, including throug...